Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viemed Healthcare (VMD) Current Deferred Revenue (2018 - 2025)

Historic Current Deferred Revenue for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $7.8 million.

  • Viemed Healthcare's Current Deferred Revenue rose 1453.29% to $7.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.8 million, marking a year-over-year increase of 1453.29%. This contributed to the annual value of $6.7 million for FY2024, which is 784.6% up from last year.
  • Latest data reveals that Viemed Healthcare reported Current Deferred Revenue of $7.8 million as of Q3 2025, which was up 1453.29% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Viemed Healthcare's Current Deferred Revenue registered a high of $7.8 million during Q3 2025, and its lowest value of $3.4 million during Q1 2021.
  • Over the past 5 years, Viemed Healthcare's median Current Deferred Revenue value was $6.0 million (recorded in 2023), while the average stood at $5.4 million.
  • In the last 5 years, Viemed Healthcare's Current Deferred Revenue soared by 82.5% in 2021 and then soared by 3539.3% in 2023.
  • Viemed Healthcare's Current Deferred Revenue (Quarter) stood at $3.8 million in 2021, then increased by 23.21% to $4.6 million in 2022, then skyrocketed by 34.23% to $6.2 million in 2023, then increased by 7.85% to $6.7 million in 2024, then rose by 16.67% to $7.8 million in 2025.
  • Its Current Deferred Revenue stands at $7.8 million for Q3 2025, versus $7.2 million for Q2 2025 and $6.8 million for Q1 2025.